missing translation for 'onlineSavingsMsg'
Learn More

REN, Mouse, Clone: 243/3 JG4, Abnova™

Mouse monoclonal antibody raised against REN.

Brand:  Abnova MAB3697.1mg

Product Code. 16065936

  • £1290.00 / 1mg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Renin catalyzes the first step in the activation pathway of angiotensinogen--a cascade that can result in aldosterone release,vasoconstriction, and increase in blood pressure. Renin, an aspartyl protease, cleaves angiotensinogen to form angiotensin I, which is converted to angiotensin II by angiotensin I converting enzyme, an important regulator of blood pressure and electrolyte balance. Transcript variants that encode different protein isoforms and that arise from alternative splicing and the use of alternative promoters have been described, but their full-length nature has not been determined. Mutations in this gene have been shown to cause familial hyperproreninemia. [provided by RefSeq

Specifications

Specifications

REN
Monoclonal
Unconjugated
The optimal working dilution should be determined by the end user.
REN
REN
Human REN.
RUO
5972
Human
Liquid
ELISA
243/3 JG4
Mouse monoclonal antibody raised against REN.
In BBS
FLJ10761
Mouse
1 mg
Primary
This antibody recognizes recombinant human renin.
Store at 4°C.
IgG1 κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.